Volume 17, Number 11—November 2011
Seasonal Influenza A Virus in Feces of Hospitalized Adults
Highlight and copy the desired format.
|EID||Chan M, Lee N, Chan P, To K, Wong R, Ho W, et al. Seasonal Influenza A Virus in Feces of Hospitalized Adults. Emerg Infect Dis. 2011;17(11):2038-2042. https://dx.doi.org/10.3201/eid1711.110205|
|AMA||Chan M, Lee N, Chan P, et al. Seasonal Influenza A Virus in Feces of Hospitalized Adults. Emerging Infectious Diseases. 2011;17(11):2038-2042. doi:10.3201/eid1711.110205.|
|APA||Chan, M., Lee, N., Chan, P., To, K., Wong, R., Ho, W....Sung, J. (2011). Seasonal Influenza A Virus in Feces of Hospitalized Adults. Emerging Infectious Diseases, 17(11), 2038-2042. https://dx.doi.org/10.3201/eid1711.110205.|
In a cohort of hospitalized adults with seasonal influenza A in Hong Kong, viral RNA was frequently (47%) detected in stool specimens. Viable virus was rarely isolated. Viral RNA positivity had little correlation with gastrointestinal symptoms and outcomes. In vitro studies suggested low potential for seasonal influenza viruses to cause direct intestinal infections.
Although influenza predominantly causes respiratory diseases, gastrointestinal signs such as diarrhea and vomiting are not uncommonly reported, particularly among young, hospitalized children (8%–38%) and immunocompromised persons (1–3). Influenza virus RNA has been detected in feces, but its role is unknown (4–7). We investigated fecal viral RNA shedding in a large cohort of hospitalized adults with seasonal influenza A in Hong Kong Special Administrative Region, People’s Republic of China. The potential of seasonal influenza viruses to cause direct intestinal infections was examined.
We conducted a prospective, observational study among adults hospitalized with laboratory-confirmed seasonal influenza A infections during 2006–2009. Hospital admission, diagnosis, and management procedures have been described (8). Briefly, patients were admitted if severe symptoms, respiratory or cardiovascular complications, or exacerbations of underlying conditions developed. When the patients sought care, nasopharyngeal aspirates (NPAs) were collected for diagnosis by using immunofluorescence assay or reverse transcription PCR. Patients with confirmed influenza A were recruited if they were >18 years of age and sought care within 1 week of illness onset. Patients with pandemic (H1N1) 2009 virus infections were excluded and reported separately (9).
After providing written, informed consent, patients were asked to submit 1 stool specimen for viral RNA detection during hospitalization, regardless of gastrointestinal symptoms. Clinical information was prospectively recorded (8). For comparison, fecal shedding of respiratory syncytial virus (RSV) and parainfluenza virus (PIV) were studied during a 10-month period by using a similar approach. Ethical approval for the study was obtained from the institutional review boards of The Chinese University of Hong Kong.
All stool specimens were subjected to influenza viral RNA detection by using quantitative real-time reverse transcription PCR targeting the matrix gene (6). If positive, virus subtyping was performed by using H1- and H3-specific conventional PCRs. Freshly collected stool specimens during 1 seasonal peak were simultaneously subjected to viral RNA detection and virus isolation by using MDCK cells. Detailed methods for fecal detection of influenza viruses and RSV and PIV are provided in the Technical Appendix [PDF - 125 KB - 4 pages].
Lectin histochemical analysis and double immunofluorescence staining were used to study the distribution of influenza virus receptors on human small and large intestinal tissues. An in vitro virus binding study on intestinal tissues was also performed by using inactivated human virus isolates of subtypes H1N1 (A/HongKong/CUHK-13003/2002) and H3N2 (A/HongKong/CUHK-22910/2004) (Technical Appendix [PDF - 125 KB - 4 pages]).
A total of 119 hospitalized adults with seasonal influenza A infections were studied (Table 1). Their median age was 71 years (interquartile range [IQR] 57–79 years), and most (66%) had concurrent conditions; ≈5% were profoundly immunosuppressed. Vomiting and diarrhea were reported by 15 (13%) and 7 (6%) patients, respectively. Influenza A viral RNA was detected in 56 of 119 of stool samples, collected at a median interval of 3 days (IQR 3–5 days) from onset (detection rates by study year and virus subtype are shown in Table 2). Detection rate by day from onset ranged from 31% to 63% and showed a trend to decrease toward the end of the week (Figure 1, panel A). Overall, the mean ± SD fecal viral RNA concentration was 4.4 ± 0.8 log10 copies/g of feces and the median (IQR) was 4.2 (3.8–5.0) log10 copies/g of feces; concentrations tended to decrease with longer time elapsed from onset (Figure 1, panel B).
In most (77%) viral RNA–positive samples, further H1- or H3-specific PCRs identified 7 cases as H1 and 36 cases as H3; unsuccessful amplification was associated with lower viral (matrix gene) concentrations (median [IQR] 3.9 [3.8–4.1] vs. 4.4 [3.8–5.1] log10 copies/g of stool; p = 0.04). No discrepancy was found between these and the subtyping results of the virus isolates from NPAs. Fecal viral RNA detection rate and concentrations were similar between H1 and H3 subtypes (Table 2).
Thirty-eight stool samples from 1 seasonal peak were subjected to virus isolation and viral RNA detection. In 10 cases, cytotoxicity occurred (procedure discontinued); in the remaining 28 cases, 12 were viral RNA positive; only 1 showed virus growth. This sample was from an 82-year-old man with dilated cardiomyopathy hospitalized for seasonal influenza A (H1N1) pneumonia and heart failure; diarrhea was absent.
Among 25 confirmed RSV or PIV infections (median [IQR] age 71 [55–79] years), viral RNA was detected in 5 fecal samples (collected at median [IQR] 4 [3–6] days after onset); none was culture positive. Fecal viral RNA positivity was lower compared with that of seasonal influenza viruses (p = 0.01).
Patients with positive and negative fecal viral RNA detection results were compared (Table 1). Positive fecal viral RNA detection was associated with younger age, shorter interval from illness onset to sample collection, lymphopenia, and positive virus isolation. Multivariate logistic regression showed that lymphopenia (adjusted odds ratio 2.36, 95% confidence interval 1.02–5.47; p = 0.045) and positive virus isolation in NPAs (adjusted odds ratio 3.76, 95% confidence interval 1.07–13.20; p = 0.039) were significant explanatory variables. No significant association was found between fecal viral RNA detection and clinical outcomes. Fecal viral RNA concentrations were also analyzed, and no association with clinical outcomes was found (data not shown), except for a negative correlation with lymphocyte count (Spearman ρ −0.37, p = 0.047).
Lectin histochemical analysis showed that sialic acid α 2,6-Gal (human-like influenza virus receptor) was absent from epithelial surface of small and large intestines and was found only in lamina propria cells. In contrast, sialic acid α 2,3-Gal (avian-like influenza virus receptor) was found on large intestinal epithelial cells and in lamina propria cells. Virus-binding study showed that neither seasonal influenza A (H1N1) nor A (H3N2) virus bind to small and large intestinal epithelial surface, but they bind to a subset of CD45+ leukocytes (Figure 2).
Direct intestinal infection by seasonal influenza viruses seems an unlikely explanation for the frequent fecal detection of viral RNA in the patients reported here. No clinical correlation was shown for RNA positivity (but was shown with lymphopenia and positive virus isolation in NPA, indicating higher virus load), and culture positivity is rare (4,5,10,11). Human-like influenza virus receptor is not found to express on normal intestinal epithelial cells (12). These findings agree with reports which showed that intestinal cells and tissues do not support efficient replication of seasonal viruses (12,13), thus their low potential to cause direct intestinal infection. Alternatively, swallowing of virus-containing nasopharyngeal secretions (although it seems inadequate to explain the higher rate of detecting fecal viral RNA than RSV or PIV) and hematogenous dissemination to organs through infected lymphocytes or macrophages in severe influenza cases with high virus load (spillover) are possible explanations for fecal viral RNA detection (2,14). Our findings on virus receptor distribution and in vitro virus binding to intestinal lamina propria leukocytes lends support to the latter hypothesis. Notably, viral RNA positivity in nonpulmonary tissues infiltrating mononuclear cells without detectable viral particles or antigens or tissue damage has been reported (15). Our study does not reject the possibility of seasonal influenza viruses causing occasional, disseminated infection in profoundly immunosuppressed persons because receptor affinity is not absolute (2). Conversely, highly pathogenic avian influenza (H5N1) and pandemic (H1N1) 2009 viruses have the ability to bind to avian-like influenza virus receptors on colonic epithelium and to replicate efficiently in intestinal cells and tissues (12). Their enhanced potential to cause direct intestinal infections and fecal–oral transmission deserve further investigation.
Dr Chan is a postdoctoral fellow at the Institute of Digestive Disease, The Chinese University of Hong Kong. His research focuses on respiratory and gastrointestinal infections, especially those caused by influenza viruses and noroviruses, respectively.
We thank Li Ka Shing Institute of Health Sciences and Stanley Ho Centre for Emerging Infectious Diseases for laboratory space and equipment.
This work was supported by the Research Fund for the Control of Infectious Diseases from the Food and Health Bureau of the Hong Kong Government (CU-09-01-02 to N.L.) and the Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong (to J.J.Y.S.). N.L. and P.K.S.C. received research grants from F. Hoffmann–La Roche Ltd., paid to The Chinese University of Hong Kong.
- Wang YH, Huang YC, Chang LY, Kao HT, Lin PY, Huang CG, Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect. 2003;36:111–6.
- Pinsky BA, Mix S, Rowe J, Ikemoto S, Baron EJ. Long-term shedding of influenza A virus in stool of immunocompromised child. Emerg Infect Dis. 2010;16:1165–7.
- Kaji M, Watanabe A, Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology. 2003;8:231–3.
- Wootton SH, Scheifele DW, Mak A, Petric M, Skowronski DM. Detection of human influenza virus in the stool of children. Pediatr Infect Dis J. 2006;25:1194–5.
- Tamura D, Fujino M, Ozawa M, Iwatsuki-Horimoto K, Goto H, Sakai-Tagawa Y, Significance of seasonal influenza viruses in the stool of pediatric patients. Pediatr Infect Dis J. 2010;29:578–9.
- Chan MC, Lee N, Chan PK, Leung TF, Sung JJ. Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms. J Clin Virol. 2009;45:208–11.
- Dilantika C, Sedyaningsih ER, Kasper MR, Agtini M, Listiyaningsih E, Uyeki TM, Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis. 2010;10:3.
- Lee N, Choi KW, Chan PK, Hui DS, Lui GC, Wong BC, Outcomes of adults hospitalised with severe influenza. Thorax. 2010;65:510–5.
- Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther. 2011;16:237–47.
- Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009;200:492–500.
- de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203–7.
- Shu Y, Li CK, Li Z, Gao R, Liang Q, Zhang Y, Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis. 2010;201:1173–7.
- Zeng H, Pappas C, Katz JM, Tumpey TM. The 2009 pandemic H1N1 and triple ressortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells. J Virol. 2011;85:686–96.
- Peiris JS, Cheung CY, Leung CY, Nicholls JM. Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol. 2009;30:574–84.
- Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007;370:1137–45.
- Figure 1. Fecal seasonal influenza A viral RNA detection rate and its concentration, by number of days after illness onset, Hong Kong, 2006–2009. A) Fecal viral RNA detection rate. Numbers in...
- Figure 2. Intestinal distribution of influenza virus receptors and in vitro binding of inactivated seasonal influenza A (H1N1) and A (H3N2) viruses to human duodenal and colonic tissues. Images in the...
- Table 1. Comparisons of baseline clinical and laboratory variables between influenza patients with positive and negative fecal viral RNA detection test results, Hong Kong, 2006–2009
- Table 2. Fecal detection of seasonal influenza A viral RNA in stool samples, by year of study and virus subtype, Hong Kong, 2006–2009
Technical AppendixCite This Article
1These authors contributed equally to this article.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Nelson Lee, 9/F Clinical Sciences Building, Division of Infectious Diseases, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 16, 2012
- Page last updated: February 16, 2012
- Page last reviewed: February 16, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)